PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsSage Therapeutics
Sage Therapeutics(SAGE)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ApomorphineApomorphine2022-02-232023-2036
Parkinson disease
,
Erectile dysfunction
ChlorhexidineChlorhexidine2005-04-252024-2027
Periodontal diseases
,
Infectious skin diseases
,
Gram-negative bacterial infections
,
Oral candidiasis
,
Gram-positive bacterial infections
,
Hypercholesterolemia
,
Coronary artery disease
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
ZulressoBrexanolone2019-06-172029-2037
Postpartum depression
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Brexanolone
psychotic disorders
,
mental disorders
,
alcoholism
,
essential tremor
,
tremor
,
alcohol drinking
,
covid-19
,
respiratory distress syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
syndrome
,
post-traumatic stress disorders
,
postpartum depression
,
depression
,
depressive disorder
,
traumatic stress disorders
,
attention deficit disorder with hyperactivity
Chlorhexidine gluconate
covid-19
,
coronavirus infections
,
dental plaque
,
gingival diseases
,
periodontal diseases
,
gingivitis
,
dental caries
,
tooth loss
,
cardiovascular diseases
,
type 2 diabetes mellitus
,
metabolic syndrome
,
periodontitis
,
syndrome
Chlorhexidine
covid-19
,
coronavirus infections
,
dental plaque
,
gingival diseases
,
periodontal diseases
,
gingivitis
,
dental caries
,
tooth loss
,
cardiovascular diseases
,
type 2 diabetes mellitus
,
metabolic syndrome
,
periodontitis
,
syndrome
Enoblituzumab
neoplasms
Cetylpyridinium chloride
covid-19
,
coronavirus infections
,
healthy volunteers/patients
,
gingivitis
,
dental plaque
Aspartame
leukemia
,
myeloid leukemia
,
ulcerative colitis
,
colitis
,
ulcer
,
rheumatoid arthritis
,
myeloid leukemia acute
,
atopic dermatitis
,
hidradenitis suppurativa
,
eczema
,
dermatitis
,
crohn disease
,
pathologic constriction
,
inflammatory bowel diseases
,
intestinal diseases
Dimethicone
actinic keratosis
,
keratosis
RIBAXAMASE
healthy volunteers/patients
,
schizophrenia
Sepranolone
covid-19
,
respiratory distress syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
syndrome
Antineoplaston a10
drug delivery systems
,
vaginitis
,
atrophic vaginitis
,
menopause
,
laron syndrome
,
healthy volunteers/patients
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
overweight
Histone-arginine methyltransferase carm1
drug interactions
Surlorian
depression
,
cognitive dysfunction
,
major depressive disorder
,
depressive disorder
,
neurocognitive disorders
,
hiv
,
sarcoma
,
acquired immunodeficiency syndrome
,
kaposi sarcoma
,
human herpesvirus 8
Corsodyl
bacteremia
,
sepsis
,
pneumonia
,
urinary tract infections
,
clostridium infections
,
infections
,
communicable diseases
,
surgical wound infection
,
cross infection
,
postoperative complications
,
ventilator-associated pneumonia
,
oral hygiene
,
staphylococcal infections
,
methicillin-resistant staphylococcus aureus
,
infectious skin diseases
,
soft tissue infections
,
asymptomatic infections
,
reinfection
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use